Stakely
investmentTelegram

Brilliant, Blind, and Wrong: How Self-Deception Trips Up Smart Investors

Investor Psychology·October 27, 2026

Brilliant, Blind, and Wrong: How Self-Deception Trips Up Smart Investors

Intelligence is not a shield against bad decisions. Elizabeth Holmes left Stanford to found Theranos, a blood-testing company that promised a wide range of lab results from a few drops of blood. She raised hundreds of millions of dollars from sophisticated backers and recruited a board of well-known public figures. The technology never worked as advertised, and Holmes was later convicted of defrauding investors and patients.

A post on the Wealth of Common Sense blog uses her story to examine self-deception, the habit of building a narrative that shields us from information we would rather not face. The lesson is not that Holmes lacked brainpower. Talent can make a flawed story more persuasive, both to the people listening and to the person telling it. A sharp mind is very good at finding reasons, and that skill can just as easily be pointed at defending a conclusion that has already been reached.

For investors, the takeaway is practical. Watch for signs that you are defending a position rather than testing it. Dismissing a critic because of who they are, feeling irritated when disconfirming data arrives, or relying on a single trusted voice are all warning signs. Simple habits help more than raw intelligence does: write down what would change your mind, seek out the strongest argument against your largest holding, and set selling or buying rules before emotions run high.

The uncomfortable point is that confidence and competence tend to make rationalization easier, not harder. The more capable you feel, the more useful it is to ask whether you are reasoning toward the truth or simply assembling reasons for what you already believe.

Reporting based on an external source.